Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial.

Snider, D E; Long, M W; Cross, F S; Farer, L S

Snider, D E; Long, M W; Cross, F S; Farer, L S.

Am Rev Respir Dis ; 129(4): 573-9, 1984 Apr.

Article in En | MEDLINE | ID: mdl-6370060

Subject(s)

Isoniazid/administration & dosage; Rifampin/administration & dosage; Tuberculosis, Pulmonary/drug therapy; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol/administration & dosage; Female; Humans; Isoniazid/adverse effects; Male; Middle Aged; Patient Compliance; Random Allocation; Rifampin/adverse effects; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Tuberculosis, Pulmonary / Isoniazid Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Am Rev Respir Dis Year: 1984 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links